language_icon
EN
HI

Aarey Drugs & Pharmaceuticals Share price

AAREYDRUGS

75.6

1.77 (-2.29%)
NSE
BSE
Last updated on 2 Jun, 2026 | 15:31 IST
Today's High

78.92

Today's Low

74.60

52 Week Low

47.76

52 Week High

100.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Aarey Drugs & Pharmaceuticals Chart

Aarey Drugs & Pharmaceuticals Share Key Metrics

Volume
35799.00
Market Cap
214.36 CR
LTQ@LTP
20@75.60
ATP
75.67
Var Margin
100 %
Circuit Range
73.51-81.23
Delivery %
0 %
Value
27.09 L
ASM/GSM
No
Market Lot
1

Summary

Aarey Drugs & Pharmaceuticals share price is ₹75.6 as of 3 Jun, 2026. The stock Aarey Drugs & Pharmaceuticals intraday movement has stayed between ₹74.60 and ₹78.92, while on a 52-week basis,Aarey Drugs & Pharmaceuticals price 52 week high is ₹100.00 & its 52 week low is ₹47.76.
In terms of trading activity, Aarey Drugs & Pharmaceuticals has recorded a volume of 35799 shares, The Aarey Drugs & Pharmaceuticals has a market cap of ₹28354303 CR. The stock’s Average Traded Price (ATP) stands at ₹75.67, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 20 @ ₹75.60.
Aarey Drugs & Pharmaceuticals operates within a circuit range of ₹73.51 – ₹81.23, with a Value of ₹27.09 L. The Delivery Percentage for the day is 0%. Additionally, Aarey Drugs & Pharmaceuticals currently falls under the No framework, and trades with a market lot size of 1.

Aarey Drugs & Pharmaceuticals Fundamentals

View More
P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

40.7

Sector P/B

2.16

Sec. Div. Yield

78.54

Aarey Drugs & Pharmaceuticals Resistance and Support

Pivot 78.12

Resistance

First Resistance

80.24

Second Resistance

83.12

Third Resistance

85.24

Support

First Support

75.24

Second Support

73.12

Third Support

70.24

Aarey Drugs & Pharmaceuticals Shareholding Pattern

View More
  • 2018-19
  • 2020-21
  • 2021-22
  • 2022-23
  • 2024-25
  • 2026-27
  • 2025-26
  • 2023-24
  • 2019-20
Total Promoters
Segment
Percent

Total Promoters

50.04%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

3.83%

Domestic Institutional Investors

0%

Retail

46.13%

Others

0%

Total Promoters
MAR '23
50.04%
JUN '23
50.04%
SEP '23
50.04%
DEC '23
50.04%

Aarey Drugs & Pharmaceuticals Corporate Actions

DateAgenda
2026-05-30Audited Results
2026-05-29Audited Results
2025-11-13Quarterly Results
2025-08-13Quarterly Results
2025-05-30Audited Results

Aarey Drugs & Pharmaceuticals News

Aarey Drugs & Pharmaceuticals Ltd - 524412 - Compliances-Reg.24(A)-Annual Secretarial Compliance

Aarey Drugs & Pharmaceuticals reported multiple non-compliances with SEBI regulations. Key issues include non-disclosure of a 7.09% promoter share sale, 1 lakh unlisted equity shares, and concerns over the completeness of insider trading data.
May 30 2026 20:19:43

Aarey Drugs & Pharmaceuticals Ltd - 524412 - Statement Of Deviation & Variation

Aarey Drugs & Pharmaceuticals has confirmed no deviation in the utilization of funds raised through convertible warrants. This ensures that the Rs. 31.90 crore raised via preferential issue has been used as per the stated objectives.
May 30 2026 20:18:19

Aarey Drugs & Pharmaceuticals Ltd - 524412 - Board Meeting Intimation for Regarding Postponement And Re-Schedule Of Board Meeting

Aarey Drugs & Pharmaceuticals' board meeting to consider and approve audited financial results for the financial year ended March 31, 2026, originally scheduled for May 29, 2026, has been postponed and rescheduled to May 30, 2026, due to unavoidable circumstances.
May 29 2026 20:14:17

Aarey Drugs & Pharmaceuticals Ltd - 524412 - Board Meeting Intimation for Approving The Audited Financial Results For The Quarter And Year Ended March 31, 2026

Aarey Drugs & Pharmaceuticals board is scheduled to meet on May 29, 2026. The agenda includes considering and approving the audited financial results for Q4 FY26 and the full financial year ended March 31, 2026.
May 25 2026 11:21:11
Read More

Aarey Drugs & Pharmaceuticals Management

NamePosition
Mihir R GhataliaChairman & Managing Director
Nimit R GhataliaWhole Time Director
View More

Aarey Drugs & Pharmaceuticals FAQs

The Buying Price of Aarey Drugs & Pharmaceuticals share is 75.6 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Aarey Drugs & Pharmaceuticals stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aarey Drugs & Pharmaceuticals, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Aarey Drugs & Pharmaceuticals shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Aarey Drugs & Pharmaceuticals shares is 0. Useful to assess the stock's value relative to its book value.

To assess Aarey Drugs & Pharmaceuticals’s valuation compare Sector P/E, P/B which are 40.7 & 2.16 with sector averages, along with growth rates and financial metrics.

The Market Cap of Aarey Drugs & Pharmaceuticals is 214.36 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Aarey Drugs & Pharmaceuticals share price is 100.00 & 47.76. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Aarey Drugs & Pharmaceuticals belongs to the Miscellaneous sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost